Cutera (NASDAQ:CUTR) Now Covered by StockNews.com

Investment analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued on Wednesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Down 63.9 %

CUTR opened at $0.04 on Wednesday. The firm has a market capitalization of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36. The stock has a fifty day moving average of $0.31 and a 200-day moving average of $0.45. Cutera has a 12-month low of $0.09 and a 12-month high of $3.00.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC increased its holdings in Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 248,257 shares of the medical device company’s stock after purchasing an additional 50,046 shares during the period. Geode Capital Management LLC owned approximately 1.23% of Cutera worth $88,000 at the end of the most recent reporting period. 90.70% of the stock is owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.